
    
      The NeuroAD system is a combined system of Transcranial Magnetic Stimulation and cognitive
      training and is a non-invasive therapeutic system for the improvement of Alzheimer patients'
      cognitive function.

      A potential participant will undergo screening procedures to confirm eligibility to
      participate in the study, followed by randomization procedure to one of the study groups -
      treatment or sham (placebo) Patient will attend the clinic 5 times a week for 6 weeks,
      approximately an hour every day for treatment/sham. The patient will be required to return to
      the clinic for follow-up.

      Up to 150 patients will be enrolled in up to 10 clinical sites in the US and Israel.
    
  